SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000812796-05-000002
Filing Date
2005-02-03
Accepted
2005-02-03 09:27:12
Documents
5
Period of Report
2005-02-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 DOR PIPE DOCUMENTS pipe0205.htm 8-K 30896
2 DOR SECURITIES PURCHASE AGREEMENT securitiespurchaseagg.htm EX-10.1 271317
3 DOR FORM OF WARRANT warrant.htm EX-10.2 98521
4 DOR REGISTRATION RIGHTS AGREEMENT registrationright.htm EX-10.3 145179
5 DOR PRESS RELEASE PIPE pressrelease.htm EX-99.1 PRESSRELEASE 17942
  Complete submission text file 0000812796-05-000002.txt   566236
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 05571524
SIC: 2834 Pharmaceutical Preparations